Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples